Compare AbCellera Biologics Inc (ABCL) vs Norfolk Southern Corporation (NSC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AbCellera Biologics Inc vs Norfolk Southern Corporation — how do they compare? AbCellera Biologics Inc trades at $9.21 (market cap $2.99B), while Norfolk Southern Corporation trades at $334 (market cap $75.15B). The key difference: Norfolk Southern Corporation is far larger — about 25.1× AbCellera Biologics Inc's market cap, and Norfolk Southern Corporation pays a 1.61% dividend while AbCellera Biologics Inc pays none. Which is the better fit depends on your goals.
| ABCL | NSC | |
|---|---|---|
Market Cap | $2.99B | $75.15B |
Sector | Health | Technology |
52-Week High | $9.76 | $350.66 |
52-Week Low | $2.78 | $272.35 |
Enterprise Value | $2.58B | $90.70B |
Dividend Yield | — | 1.61% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About Norfolk Southern Corporation
Norfolk Southern Corporation is a major North American railroad company operating one of the largest freight rail networks in the eastern United States. The company transports a diverse range of commodities, including coal, intermodal containers, and various industrial products. NSC is a critical link in the nation's supply chain, providing efficient, long-haul transportation services to and from ports and industrial centers.
Read more on NSC →
